anti-kappa Light Chain antibody (PE) | Product No. ABIN1027676
Human Ig Kappa Light Chain Antibody MAB10050-100: R&D Systems
Kappa and lambda light chain mRNA in situ hybridization compared to flow cytometry and immunohistochemistry in B cell lymphomas | Diagnostic Pathology | Full Text
Lambda-Carrageenan - an overview | ScienceDirect Topics
International Clinical Cytometry Society
Signaling Properties of Structurally Diverse Kappa Opioid Receptor Ligands: Toward in Vitro Models of in Vivo Responses | ACS Chemical Neuroscience
Cells | Free Full-Text | Interleukin-1 and Nuclear Factor Kappa B Signaling Promote Breast Cancer Progression and Treatment Resistance
Immune system - Classes of immunoglobulins | Britannica
Evolution of the variant surface glycoprotein family in African trypanosomes: Trends in Parasitology
Protein L - Wikipedia
A generic cell surface ligand system for studying cell–cell recognition | PLOS Biology
A generic cell surface ligand system for studying cell–cell recognition | PLOS Biology
Structural and biochemical rationale for enhanced spike protein fitness in delta and kappa SARS-CoV-2 variants | Nature Communications
Page 1 of 9 Title: Flow Cytometric Testing for Kappa and Lambda light chains Sponsored and reviewed by ICCS Quality and Standar
Case 966-- Clinical Chemistry Case
Structural and biochemical rationale for enhanced spike protein fitness in delta and kappa SARS-CoV-2 variants | Nature Communications
The current role of clinical flow cytometry in the evaluation of mature B‐cell neoplasms - Seegmiller - 2019 - Cytometry Part B: Clinical Cytometry - Wiley Online Library
Methods for Systematic Identification of Membrane Proteins for Specific Capture of Cancer-Derived Extracellular Vesicles - ScienceDirect
How to Select Chromatography Media for the Purification of Antibodies
Antibody Basics
Nanodisc technology facilitates identification of monoclonal antibodies targeting multi-pass membrane proteins | Scientific Reports
Kappa-on-Heavy (KoH) bodies are a distinct class of fully-human antibody-like therapeutic agents with antigen-binding properties | PNAS
Covalently Engineered Protein Minibinders with Enhanced Neutralization Efficacy against Escaping SARS-CoV-2 Variants | Journal of the American Chemical Society
Frontiers | Interaction Between Virus-Like Particles (VLPs) and Pattern Recognition Receptors (PRRs) From Dendritic Cells (DCs): Toward Better Engineering of VLPs
Paired heavy- and light-chain signatures contribute to potent SARS-CoV-2 neutralization in public antibody responses - ScienceDirect
